LYONS GARY A Insider Trades

Insider Trading History

Track insider trading activity for LYONS GARY A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $424k 2,624 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$609k 3,908 shares
$155.83
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $19.7M 122,141 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$258k 1,659 shares
$155.50
$161.44
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.44M 61,500 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 4,000 shares
$42.26
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $671k 12,000 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$507k 12,000 shares
$42.26
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.22M 57,500 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$329k 8,000 shares
$41.07
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.66M 65,500 shares
Last Trade
Apr 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 8,000 shares
$42.13
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $0 0 shares
Last Trade
Apr 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$337k 8,000 shares
$42.13
$55.95
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $19.5M 120,482 shares
Last Trade
Dec 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.29M 15,000 shares
$152.61
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $21.9M 135,482 shares
Last Trade
Dec 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 15,000 shares
$151.96
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Dec 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.28M 15,000 shares
$151.96
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $19.5M 120,482 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$171k 1,435 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $534k 3,305 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 3,305 shares
$120.56
$161.44
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.22M 57,500 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$412k 19,500 shares
$21.15
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $3.91M 69,821 shares
Last Trade
Oct 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$589k 40,000 shares
$14.73
$55.95
Travere Therapeutics
Travere Therapeutics TVTX
Director
Holding Value $5.09M 91,000 shares
Last Trade
Oct 04, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$609k 40,000 shares
$15.23
$55.95
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $19.2M 119,047 shares
Last Trade
Aug 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.74M 11,570 shares
$150.43
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $21.1M 130,617 shares
Last Trade
Aug 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.74M 11,570 shares
$150.70
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Aug 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.74M 11,570 shares
$150.70
$161.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up